A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines

Journal for Immunotherapy of Cancer
Dina SchneiderRimas J Orentas

Abstract

Clinical success with chimeric antigen receptor (CAR)- based immunotherapy for leukemia has been accompanied by the associated finding that antigen-escape variants of the disease are responsible for relapse. To target hematologic malignancies with a chimeric antigen receptor (CAR) that targets two antigens with a single vector, and thus potentially lessen the chance of leukemic escape mutations, a tandem-CAR approach was investigated. Antigen binding domains from the FMC63 (anti-CD19) and Leu16 (anti-CD20) antibodies were linked in differing configurations to transmembrane and T cell signaling domains to create tandem-CARs. Expression on the surface of primary human T cells was induced by transduction with a single lentiviral vector (LV) encoding the tandem-CAR. Tandem-CARs were compared to single antigen targeting CARs in vitro and in vivo, and to an admixture of transduced cells expressing each CAR in vivo in immunodeficient (NSG) disease-bearing mice. Tandem constructs efficient killed the Raji leukemia cell line both in vitro and in vivo. Tandem CARs generated less cytokine than the CD20 CAR, but similar to CD19 CARs, on their own. In co-culture experiments at low effector to target ratios with both single- and tandem- CAR-...Continue Reading

References

Aug 26, 1998·Journal of Clinical Pathology·L GinaldiD Catovsky
Oct 8, 1998·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·M JensenA Raubitschek
Dec 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dennis C OteroRobert C Rickert
Nov 25, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dennis C Otero, Robert C Rickert
Dec 31, 2008·Journal of Virological Methods·Hitoshi KurodaJakob Reiser
Jun 30, 2009·Journal of Immunotherapy·James N KochenderferSteven A Rosenberg
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
May 2, 2012·The Journal of Clinical Investigation·Elaine Y ChungAndrei Thomas-Tikhonenko
May 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel W LeeStephan A Grupp
Jul 25, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jonathan C PoeThomas F Tedder
Mar 27, 2013·The New England Journal of Medicine·Stephan A GruppCarl H June
Apr 27, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael HudecekStanley R Riddell
Jul 11, 2013·Molecular Therapy. Nucleic Acids·Zakaria GradaNabil Ahmed
Nov 12, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Usanarat AnurathapanJuan F Vera
Aug 30, 2016·The Journal of Clinical Investigation·Marco RuellaSaar Gill

❮ Previous
Next ❯

Citations

Jan 10, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shivani Srivastava, Stanley R Riddell
Nov 28, 2017·Current Opinion in Pediatrics·Jessica B Foster, Shannon L Maude
Sep 1, 2017·Nature Reviews. Clinical Oncology·Jennifer N Brudno, James N Kochenderfer
Dec 7, 2017·Human Gene Therapy·Alexandra MartyniszynHinrich Abken
Jan 10, 2018·Frontiers in Immunology·Yuedi WangYiwei Chu
Jan 12, 2019·American Journal of Hematology·Mark B Leick, Marcela V Maus
Feb 5, 2019·Frontiers in Immunology·Alka DwivediRahul Purwar
Feb 21, 2019·American Journal of Hematology·Noelle V Frey
Apr 12, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·David A McBrideNisarg J Shah
May 1, 2019·Expert Opinion on Biological Therapy·Caroline M Hull, John Maher
Jul 30, 2019·Immunological Reviews·Zachary WalshM Eric Kohler
Jan 31, 2020·Blood·Nirali N Shah
Oct 19, 2019·Leukemia·Dongpeng JiangJianhong Chu
May 1, 2020·Cytometry. Part B, Clinical Cytometry·Elena MaryamchikMarcela V Maus
Jun 22, 2019·Journal of Hematology & Oncology·Jianshu WeiWeidong Han
Oct 1, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·S TahmasebiA Esmaeilzadeh
Jul 23, 2018·Journal of Experimental & Clinical Cancer Research : CR·Michelle H TownsendKim L O'Neill
Aug 19, 2018·Current Hematologic Malignancy Reports·Katherine C PehlivanDaniel W Lee
Nov 8, 2018·International Journal of Molecular Sciences·Xingjian GuGuanghua Yang
May 18, 2019·American Society of Clinical Oncology Educational Book·Jeremy S AbramsonM Lia Palomba
Jul 25, 2019·Current Hematologic Malignancy Reports·Zachary WalshTerry J Fry
Jul 28, 2020·Science China. Life Sciences·Dongdong TiWeidong Han
Apr 16, 2019·Frontiers in Oncology·Nicholas G MinutoloDaniel J Powell
Mar 28, 2019·Frontiers in Oncology·Nirav N ShahBryon Johnson
Aug 28, 2020·Frontiers in Immunology·Zachary JacksonJane S Reese
Aug 28, 2020·Frontiers in Oncology·Jort J van der SchansTuna Mutis
Mar 7, 2019·Nature Reviews. Clinical Oncology·Nirali N Shah, Terry J Fry
Jan 17, 2020·Nature Communications·Norris LamJames N Kochenderfer
Aug 9, 2020·Cancers·Thomas J GardnerDavid Scheinberg
Oct 20, 2017·Expert Review of Anticancer Therapy·Jinjing XuJunnian Zheng
Nov 24, 2018·Frontiers in Immunology·Andrea Schmidts, Marcela V Maus
Dec 8, 2019·Cancer Metastasis Reviews·Hiroto Inaba, Ching-Hon Pui
Jul 10, 2018·Memo·Philipp WohlfarthGeorg Hopfinger

❮ Previous
Next ❯

Datasets Mentioned

BETA
HM852952.1
GM-CSF

Methods Mentioned

BETA
transfection
flow cytometry

Software Mentioned

Living Image
Image Studio lite
GraphPad Prism
Image Studio

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.